The Duke Human Vaccine Institute (DHVI) is pleased to announce that Susanna Naggie, MD, MHS, has joined the DHVI as an affiliate faculty member.
The Duke Human Vaccine Institute is pleased to announce that Dr. Chen-Hao Yeh has been promoted to the faculty position of Assistant Professor in the Department of Medicine at Duke, effective March 1, 2023.
The Duke Human Vaccine Institute is pleased to announce that Dr. Kevin O. Saunders has been promoted to Associate Professor in Surgery (tenure) effective July 1, 2022.
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to the Duke Human Vaccine Institute - Immunology Virology Quality Assessment Center’s (DHVI-IVQAC) Biorepository based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs. This biorepository accreditation covers the biorepository of Peripheral Blood Mononuclear cells (PBMCs) General Specimen Processing, Long Term Storage, and Distribution.
Duke Human Vaccine Institute to Serve as National Coordinating Center in Fight Against Influenza, COVID-19 and Respiratory Viruses
DHVI receives $4.9 million grant from CDC to serve seven U.S. sites
The Top 25 Healthcare Technology COOs of 2022 were announced in the Healthcare Technology Report.
The Duke Human Vaccine Institute (DHVI) is pleased to announce that Cameron Wolfe, MBBS, has joined the DHVI as an affiliate faculty member, effective July 1, 2022. Dr. Wolfe is an associate professor of medicine and serves as the director of Biological and Emergency Preparedness for the Duke University Hospital System with a specific focus on influenza, SARS-CoV-2 and other respiratory viral pathogens. He has worked closely with the DHVI’s chief medical officer, Dr.